A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study
Public ClinicalTrials.gov record NCT01519778. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Open-Label Safety and Exploratory Skin Lesion Measurement Study of 6-Day Oral TR-701 FA in Skin Abscess and Cellulitis Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Characterization of the safety profile of TR-701 Free Acid (FA) in patients with major cutaneous abscess or cellulitis/erysipelas.
Study identification
- NCT ID
- NCT01519778
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2012 (Actual)
- Primary completion
- Aug 27, 2012 (Actual)
- Completion
- Aug 27, 2012 (Actual)
- Last update posted
- Aug 29, 2018
2012
United States locations
- U.S. sites
- 10
- U.S. states
- 4
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Trius Investigator Site #118 | Anaheim | California | 92804 | — |
| Trius Investigator Site #129 | Buena Park | California | 90620 | — |
| Trius Investigator Site 103 | Chula Vista | California | 91911 | — |
| Trius Investigator Site 105 | La Mesa | California | 91942 | — |
| Trius Investigator Site #106 | Long Beach | California | 90813 | — |
| Trius Investigator Site 104 | Oceanside | California | 92056 | — |
| Trius Investigator Site 101 | Columbus | Georgia | 31904 | — |
| Trius Investigator Site 102 | Savannah | Georgia | 31406 | — |
| Trius Investigator Site 128 | Las Vegas | Nevada | 89109 | — |
| Trius Investigator Site 115 | Somers Point | New Jersey | 08244 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01519778, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 29, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01519778 live on ClinicalTrials.gov.